Building shared, scalable biomanufacturing infrastructure does more than support a single program. It transforms the entire translational ecosystem.
It accelerates therapeutic advancement by removing the prohibitive cost and complexity of manufacturing, enabling engineered tissue technologies to move from laboratory discovery to clinical development more efficiently and reliably.
Responding to the policy shift away from animal testing with human-relevant alternative enable by the establishment of foundational manufacturing.
This manufacturing enables the transition away from animal models. As federal policy and scientific consensus move toward human-relevant systems, this infrastructure provides scalable, biologically accurate test beds that improve predictive validity while reducing reliance on outdated models.
It anchors advanced scientific talent and durable, high-skill employment in Pennsylvania, driving sustained economic growth and long-term competitiveness.
Syntherian’s mission also aims to strengthen Pennsylvania’s scientific and economic foundation by retaining highly educated talent, attracting translational leaders, and creating durable, high-skill jobs that generate long-term growth.